BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Gut microbiota from green tea polyphenol-dosed mice improves intestinal epithelial homeostasis and ameliorates experimental colitis. ✅
Go to Publication ✅
Microbiome (Microbiome ) Vol: 9 Issue 1 Pages: 184 Pub: 2021 Sep 7 Epub: 2021 Sep 7 Authors Wu Z , Huang S , Li T , Li N , Han D , Zhang B , Xu ZZ , Zhang S , Pang J , Wang S , Zhang G , Zhao J , Wang J , |
|
|
Mechanisms of epigallocatechin gallate (EGCG) in ameliorating hyperuricemia: insights into gut microbiota and intestinal function in a mouse model. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 15 Issue 11 Pages: 6068-6081 Pub: 2024 Jun 4 Epub: 2024 Jun 4 Authors Yu H , Lou Z , Wu T , Wan X , Huang H , Wu Y , Li B , Tu Y , He P , Liu J , |
|
|
Liposomal Epigallocatechin-3-Gallate for the Treatment of Intestinal Dysbiosis in Children with Autism Spectrum Disorder: A Comprehensive Review. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 15 Issue 14 Pages: Pub: 2023 Jul 24 Epub: 2023 Jul 24 Authors de la Rubia Ortí JE , Moneti C , Serrano-Ballesteros P , Castellano G , Bayona-Babiloni R , Carriquí-Suárez AB , Motos-Muñoz M , Proaño B , Benlloch M , |
|
|
Tea polyphenol and epigallocatechin gallate ameliorate hyperlipidemia via regulating liver metabolism and remodeling gut microbiota. ✅
Go to Publication ✅
Food chemistry (Food Chem ) Vol: 404 Issue Pt A Pages: 134591 Pub: 2023 Mar 15 Epub: 2022 Oct 14 Authors Wen JJ , Li MZ , Chen CH , Hong T , Yang JR , Huang XJ , Geng F , Hu JL , Nie SP , |
|
|
Reciprocal Interactions between Epigallocatechin-3-gallate (EGCG) and Human Gut Microbiota In Vitro. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 68 Issue 36 Pages: 9804-9815 Pub: 2020 Sep 9 Epub: 2020 Aug 26 Authors Liu Z , de Bruijn WJC , Bruins ME , Vincken JP , |
|
|
Combined use of epigallocatechin-3-gallate (EGCG) and caffeine in low doses exhibits marked anti-obesity synergy through regulation of gut microbiota and bile acid metabolism. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 12 Issue 9 Pages: 4105-4116 Pub: 2021 May 11 Epub: Authors Zhu MZ , Zhou F , Ouyang J , Wang QY , Li YL , Wu JL , Huang JA , Liu ZH , |
|
|
Epigallocatechin-3-gallate (EGCG) attenuates non-alcoholic fatty liver disease via modulating the interaction between gut microbiota and bile acids. ✅
Go to Publication ✅
Journal of clinical biochemistry and nutrition (J Clin Biochem Nutr ) Vol: 67 Issue 1 Pages: 2-9 Pub: 2020 Jul Epub: 2020 Jun 3 Authors Naito Y , Ushiroda C , Mizushima K , Inoue R , Yasukawa Z , Abe A , Takagi T , |
|
|
Examination of sex-specific interactions between gut microbiota and host metabolism after 12-week combined polyphenol supplementation in individuals with overweight or obesity. ✅
Go to Publication ✅
Gut microbes (Gut Microbes ) Vol: 16 Issue 1 Pages: 2392875 Pub: 2024 Jan-Dec Epub: 2024 Aug 25 Authors Jardon KM , Goossens GH , Most J , Galazzo G , Venema K , Penders J , Blaak EE , |
|
|
Examination of sex-specific interactions between gut microbiota and host metabolism after 12-week combined polyphenol supplementation in individuals with overweight or obesity. ✅
Go to Publication ✅
Gut microbes (Gut Microbes ) Vol: 16 Issue 1 Pages: 2392875 Pub: 2024 Jan-Dec Epub: 2024 Aug 25 Authors Jardon KM , Goossens GH , Most J , Galazzo G , Venema K , Penders J , Blaak EE , |
|
|
Examination of sex-specific interactions between gut microbiota and host metabolism after 12-week combined polyphenol supplementation in individuals with overweight or obesity. ✅
Go to Publication ✅
Gut microbes (Gut Microbes ) Vol: 16 Issue 1 Pages: 2392875 Pub: 2024 Jan-Dec Epub: 2024 Aug 25 Authors Jardon KM , Goossens GH , Most J , Galazzo G , Venema K , Penders J , Blaak EE , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
